Data presented at 2020 ESMO virtual congress
Swiss pharma company to acquire biotech for $449m (€380m)
Both PARP inhibitors receive positive opinions from CHMP
Decision made following review of rising COVID-19 cases
Viral vector manufacturer Vibalogics adds CEO to lead expansion, COVID-19 response kblankenship Mon, 09/21/2020 – 19:14
Updated Date: Mon, 14 Sep 2020 00:00:00 EDT
Updated Date: Mon, 14 Sep 2020 00:00:00 EDT
Two open letters sent to the UK’s four chief medical officers signal the polarisation of opinion among medical […]
Holst and colleagues discuss the asthma risk to children of being exposed to fine particular matter (PM2.5).1 Their […]
The Independent Scientific Advisory Group for Emergencies has published an emergency 10 point plan to avoid a national […]